Cargando…
Management of Hypertension in Fabry Disease
Fabry disease (FD), a rare X-linked lysosomal storage disorder that depletes alpha-galactosidase A (α-GalA), is caused by mutations in the GLA gene. Diminished α-GalA enzyme activity results in the accumulation of Gb3 and lyso-Gb3. The pathophysiology of hypertension in FD is complex and unclear. Th...
Autores principales: | Kim, Su Hyun, Choi, Soo Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte Metabolism
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329903/ https://www.ncbi.nlm.nih.gov/pubmed/37434805 http://dx.doi.org/10.5049/EBP.2023.21.1.8 |
Ejemplares similares
-
Multidisciplinary Management of Fabry Disease: Current Perspectives
por: Paim-Marques, Luciana, et al.
Publicado: (2022) -
Fabry disease
por: Germain, Dominique P
Publicado: (2010) -
Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011) -
Update on role of agalsidase alfa in management of Fabry disease
por: Ramaswami, Uma
Publicado: (2011) -
Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
por: Waldek, Stephen, et al.
Publicado: (2014)